Capital Fund Management (CFM)
AUPH icon

Capital Fund Management (CFM)’s Aurinia Pharmaceuticals AUPH Stock Holding History

Capital Fund Management (CFM)’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$704K Buy
+41,483
New +$663K ﹤0.01% 1804
2025
Q1 		– Sell
-22,458
Closed -$202K – 1977
2024
Q4 		$202K Sell
22,458
-5,111
-19% -$41.7K ﹤0.01% 1994
2024
Q3 		$202K Sell
27,569
-42,190
-60% -$262K ﹤0.01% 1937
2024
Q2 		$398K Sell
69,759
-9,075
-12% -$47.8K ﹤0.01% 1795
2024
Q1 		$395K Buy
78,834
+1,200
+2% +$8.14K ﹤0.01% 1899
2023
Q4 		$698K Sell
77,634
-82,884
-52% -$683K ﹤0.01% 1922
2023
Q3 		$1.25M Buy
160,518
+99,678
+164% +$975K ﹤0.01% 1562
2023
Q2 		$589K Buy
60,840
+36,331
+148% +$377K ﹤0.01% 1544
2023
Q1 		$269K Buy
+24,509
New +$216K ﹤0.01% 1512
2022
Q4 		– Sell
-190,104
Closed -$1.43M – 1392
2022
Q3 		$1.43M Buy
190,104
+48,360
+34% +$419K 0.01% 963
2022
Q2 		$1.42M Sell
141,744
-606
-0.4% -$6.77K 0.01% 949
2022
Q1 		$1.76M Buy
+142,350
New +$2.2M 0.01% 1004

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Fund Management (CFM)'s AUPH Position: Q2 2026 in Review

Capital Fund Management (CFM) opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 41,483 shares worth $704K. The stake represents ﹤0.01% of the portfolio and ranks #1804 among its holdings. This is a return to the name: Capital Fund Management (CFM) previously reported a position in AUPH as recently as Q4 2024.

Capital Fund Management (CFM) first reported a position in AUPH in Q1 2022 and has held it in 12 quarters since. The position peaked at $1.76M in Q1 2022. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Capital Fund Management (CFM) held 41,483 shares of Aurinia Pharmaceuticals worth $704K as of Q2 2026.
  • Aurinia Pharmaceuticals was a new Capital Fund Management (CFM) position in Q2 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #1804 holding.
  • Capital Fund Management (CFM) first reported a position in Aurinia Pharmaceuticals in Q1 2022 and has held it in 12 quarters since.
  • Capital Fund Management (CFM)'s Aurinia Pharmaceuticals position peaked at $1.76M in Q1 2022.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.